Acquisition protocols and correction methods for estimation of the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging

Journal of Nuclear Medicine

Volumn 54, Issue 5, 2013, Pages 707-713

  Inoue, Yusuke ^a   Abe, Yutaka ^b   Itoh, Yoshihiro ^b   Asano, Yuji ^a   Kikuchi, Kei ^b   Sakamoto, Yutaka ^b   Matsunaga, Keiji ^a   Ogino, Yutaka ^a   Iizuka, Takahiro ^a   Mochizuki, Hideki ^c  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

123i metaiodobenzylguanidine (MIBG); Collimator; Energy window; Heart to mediastinum (H M) ratio; Septal penetration

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

AGED; ARTICLE; CARDIAC SYMPATHETIC IMAGING; CLINICAL PROTOCOL; COLLIMATOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART SIZE; HEART TO MEDIASTINUM RATIO; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PHOTON; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; THORAX RADIOGRAPHY;

123I-METAIODOBENZYLGUANIDINE (MIBG); COLLIMATOR; ENERGY WINDOW; HEART-TO-MEDIASTINUM (H/M) RATIO; SEPTAL PENETRATION;

3-IODOBENZYLGUANIDINE; AGED; FEMALE; HEART; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MEDIASTINUM; RETROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM;

EID: 84877141031     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.111955     Document Type: Article

References (19)

1. Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3:92-100.
2. Treglia G, Cason E, Stefanelli A, et al. MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clin Auton Res. 2012;22:43-55.
3. King AE, Mintz J, Royall DR. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord. 2011;26:1218-1224.
4. 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation. Eur J Nucl Med Mol Imaging. 2008;35:547-553.
5. van der Veen L, Scholte A, Stokkel M. Mathematical methods to determine quantitative parameters of myocardial 123I-MIBG studies: a review of the literature. Nucl Med Commun. 2010;31:617-628.
6. 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802-1812.
7. Nakajima K, Matsubara K, Ishikawa T, et al. Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio. J Nucl Cardiol. 2007;14:843-851. (Pubitemid 350082578)
8. 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations. Eur J Nucl Med Mol Imaging. 2009;36:560-566.
9. Nakajima K, Okuda K, Matsuo S, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging. 2012;39:113-119.
10. Inoue Y, Suzuki A, Shirouzu I, et al. Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol. 2003;10:623-632. (Pubitemid 38035397)
11. 123I-MIBG heart/mediastinum ratios: a phantom study. Eur J Nucl Med Mol Imaging. 2005;32:1100-1107.
12. Macey DJ, DeNardo GL, DeNardo SJ, Hines HH. Comparison of low- and medium-energy collimators for SPECT imaging with iodine-123-labeled antibodies. J Nucl Med. 1986;27:1467-1474. (Pubitemid 17028570)
13. Geeter FD, Franken PR, Defrise M, Andries H, Saelens E, Bossuyt A. Optimal collimator choice for sequential iodine-123 and technetium-99m imaging. Eur J Nucl Med. 1996;23:768-774. (Pubitemid 26237870)
14. Dobbeleir AA, Hambÿe AS, Franken PR. Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice. Eur J Nucl Med. 1999;26:655-658. (Pubitemid 29263637)
15. 123I imaging and simultaneous dual-isotope imaging. Nucl Med Commun. 2003;24:1195-1202.
16. Kobayashi H, Momose M, Kanaya S, Kondo C, Kusakabe K, Mitsuhashi N. Scatter correction by two-window method standardizes cardiac I-123 MIBG uptake in various gamma camera systems. Ann Nucl Med. 2003;17:309-313. (Pubitemid 37012044)
17. Gilland DR, Jaszczak RJ, Turkington TG, Greer KL, Coleman RE. Volume and activity quantitation with iodine-123 SPECT. J Nucl Med. 1994;35:1707-1713. (Pubitemid 24307769)
18. Inoue Y, Shirouzu I, Machida T, et al. Collimator choice in cardiac SPECT with I-123-labeled tracers. J Nucl Cardiol. 2004;11:433-439. (Pubitemid 39107081)
19. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008;1:131-140.